본문 바로가기
KERD
논문KCI 등재

신경항법을 이용한 반복적 경두개자기자극의 적용 위치 선정 방법과 우울증 치료 효과 고찰

A Review on Neuronavigated Repetitive Transcranial Magnetic Stimulation and Its Antidepressant Effect

김정윤|마지영|송유미|홍가혜|김명주|서채원
대한생물치료정신의학회 (Korean Society Of Biological Therapies In Psychiatry)|2020.06|생물치료정신의학 (Journal of the Korean Society of Biological Therapies in Psychiatry)|제26권 제2호|pp. 101-115|DOI 10.22802/jksbtp.2020.26.2.101

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

Depression우울증경두개자기자극술Transcranial magnetic stimulationNeuroimaging뇌영상신경항법Neuronavigation
주제분류정신과학

초록

Repetitive transcranial magnetic stimulation (rTMS) is widely recognized as an effective and noninvasive neuromodulation for treating depression, and has been applied in a wide range of clinical settings. However, previous studies often reported inconsistent antidepressant effects that may be due to differences in the rTMS protocols such as coil placement. The typical simulation site for rTMS depression protocol is the left dorsolateral prefrontal cortex (DLPFC). Targeting the exact site of the left DLPFC while considering individual brain structure has been challenging due to the non-invasive nature of rTMS. Several researchers have applied various targeting methods to overcome the abovementioned issue. Most of the previous studies have applied the “5-cm rule” or the “international 10-20 system,” which is easily applicable. Recently, researchers started to apply a neuronavigation system that targets the stimulation site based on neuroimaging of each individual. Pros and cons of targeting methods have been discussed in terms of validity and reliability of targeting stimulation sites, differences in treatment responses, as well as considerations of individual characteristics. Therefore, the current review focuses on the targeting methods of stimulation site and the treatment effects of depression in previous studies. For discussion, we divided neuronavigation methods into using fixed coordinates and using individualized targets. Furthermore, the limitations of each targeting method are discussed that may potentially contribute to the development of the optimal rTMS protocol for depression treatment.

Abstract

Repetitive transcranial magnetic stimulation (rTMS) is widely recognized as an effective and noninvasive neuromodulation for treating depression, and has been applied in a wide range of clinical settings. However, previous studies often reported inconsistent antidepressant effects that may be due to differences in the rTMS protocols such as coil placement. The typical simulation site for rTMS depression protocol is the left dorsolateral prefrontal cortex (DLPFC). Targeting the exact site of the left DLPFC while considering individual brain structure has been challenging due to the non-invasive nature of rTMS. Several researchers have applied various targeting methods to overcome the abovementioned issue. Most of the previous studies have applied the “5-cm rule” or the “international 10-20 system,” which is easily applicable. Recently, researchers started to apply a neuronavigation system that targets the stimulation site based on neuroimaging of each individual. Pros and cons of targeting methods have been discussed in terms of validity and reliability of targeting stimulation sites, differences in treatment responses, as well as considerations of individual characteristics. Therefore, the current review focuses on the targeting methods of stimulation site and the treatment effects of depression in previous studies. For discussion, we divided neuronavigation methods into using fixed coordinates and using individualized targets. Furthermore, the limitations of each targeting method are discussed that may potentially contribute to the development of the optimal rTMS protocol for depression treatment.

참고문헌 (92)

  1. Perera T, "The clinical TMS society consensus review and treatment recommendations for TMS therapy for major depressive disorder", Brain Stimul, 9, pp.336~346 (2016)
  2. Hoogendam JM, "Physiology of repetitive transcranial magnetic stimulation of the human brain", Brain Stimul, 3, pp.95~118 (2010)
  3. Mutz J, "Efficacy and acceptability of non-invasive brain stimulation for the treatment of adult unipolar and bipolar depression : a systematic review and meta-analysis of randomised sham-controlled trials", Neurosci Biobehav Rev, 92, pp.291~303 (2018)
  4. Trevizol AP, "An update on repetitive transcranial magnetic stimulation for the treatment of major depressive disorder", Clin Pharmacol Ther, 106, pp.747~762 (2019)
  5. Pascual-Leone A, "Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression", Lancet, 348, pp.233~237 (1996)
  6. George MS, "Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder : a sham-controlled randomized trial", Arch Gen Psychiatry, 67, pp.507~516 (2010)
  7. Liston C, "Default mode network mechanisms of transcranial magnetic stimulation in depression", Biol Psychiatry, 76, pp.517~526 (2014)
  8. Baxter LR, "Reduction of prefrontal cortex glucose metabolism common to three types of depression", Arch Gen Psychiatry, 46, pp.243~250 (1989)
  9. Bench CJ, "Changes in regional cerebral blood flow on recovery from depression", Psychol Med, 25, pp.247~261 (1995)
  10. Pascual-Leone A, "Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex", Brain, 117, pp.847~858 (1994)
  11. Chen R, "Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation", Neurology, 48, pp.1398~1403 (1997)
  12. Teneback CC, "Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS", J Neuropsychiatr Clin Neurosci, 11, pp.426~435 (1999)
  13. Paus T, "Transcranial magnetic stimulation(TMS)of the human frontal cortex : implications for repetitive TMS treatment of depression", J Psychiatry Neurosci, 29, pp.268~279 (2004)
  14. Tik M, "Towards understanding rTMS mechanism of action : stimulation of the DLPFC causes network-specific increase in functional connectivity", Neuroimage, 162, pp.289~296 (2017)
  15. Gershon AA, "Transcranial magnetic stimulation in the treatment of depression", Am J Psychiat, 160, pp.835~845 (2003)
  16. Fitzgerald PB, "A study of the pattern of response to rTMS treatment in depression", Depress Anxiety, 33, pp.746~753 (2016)
  17. Fox MD, "Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate", Biol Psychiatry, 72, pp.595~603 (2012)
  18. Herwig U, "The navigation of transcranial magnetic stimulation", Psychiatry Res Neuroimaging, 108, pp.123~131 (2001)
  19. Rajkowska G, "Cytoarchitectonic definition of prefrontal areas in the normal human cortex:II. Variability in locations of areas 9 and 46 and relationship to the Talairach coordinate system", Cereb Cortex, 5, pp.323~337 (1995)
  20. Opitz A, "An integrated framework for targeting functional networks via transcranial magnetic stimulation", Neuroimage, 127, pp.86~96 (2016)
  21. Fitzgerald PB, "A randomized trial of rTMS targeted with MRI based neuro-navigation in treatment-resistant depression", Neuropsychopharmacology, 34, pp.1255~1262 (2009)
  22. Herbsman T, "More lateral and anterior prefrontal coil location is associated with better repetitive transcranial magnetic stimulation antidepressant response", Biol Psychiatry, 66, pp.509~515 (2009)
  23. Schönfeldt-Lecuona C, "The value of neuronavigated rTMS for the treatment of depression", Neurophysiol Clin, 40, pp.37~43 (2010)
  24. George MS, "Daily repetitive transcranial magnetic stimulation(rTMS)improves mood in depression", Neuroreport, 6, pp.1853~1856 (1995)
  25. O’Reardon JP, "Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression : a multisite randomized controlled trial", Biol Psychiatry, 62, pp.1208~1216 (2007)
  26. Herwig U, "Transcranial magnetic stimulation in therapy studies : examination of the reliability of"standard"coil positioning by neuronavigation", Biol Psychiatry, 50, pp.58~61 (2001)
  27. Peleman K, "Using 3D-MRI to localize the dorsolateral prefrontal cortex in TMS research", World J Biol Psychiatry, 11, pp.425~430 (2010)
  28. Bradfield NI, "Stereotaxic localisation of the dorsolateral prefrontal cortex for transcranial magnetic stimulation is superior to the standard reference position", Aust N Z J Psych, 46, pp.232~239 (2012)
  29. Rossi S, "Prefontal cortex in long-term memory : an"interference"approach using magnetic stimulation", Nat Neurosci, 4, pp.948~952 (2001)
  30. Herwig U, "Using the international 10-20 EEG system for positioning of transcranial magnetic stimulation", Brain Topogr, 16, pp.95~99 (2003)
  31. Klem GH, "The tentwenty electrode system of the International Federation", Electroencephalogr Clin Neurophysiol, 52, pp.3~6 (1999)
  32. Plewnia C, "Treatment of major depression with bilateral theta burst stimulation : a randomized controlled pilot trial", J Affect Disord, 156, pp.219~223 (2014)
  33. Lefaucheur JP, "Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation(rTMS) : an update(2014-2018)", Clin Neurophysiol, 131, pp.474~528 (2020)
  34. Beam W, "An efficient and accurate new method for locating the F3 position for prefrontal TMS applications", Brain Stimul, 2, pp.50~54 (2009)
  35. Mir-Moghtadaei A, "Concordance between BeamF3and MRI-neuronavigated target sites for repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex", Brain Stimul, 8, pp.965~973 (2015)
  36. Loo CK, "A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy", J Affect Disord, 88, pp.255~267 (2005)
  37. Sparing R, "Transcranial magnetic stimulation and the challenge of coil placement : a comparison of conventional and stereotaxic neuronavigational strategies", Hum Brain Mapp, 29, pp.82~96 (2008)
  38. Krings T, "Introducing navigated transcranial magnetic stimulation as a refined brain mapping methodology", Neurosurg Rev, 24, pp.171~179 (2001)
  39. Ruohonen J, "Navigated transcranial magnetic stimulation", Neurophysiol Clin, 40, pp.7~17 (2010)
  40. Herwig U, "Add-on rTMS for treatment of depression : a pilot study using stereotaxic coil-navigation according to PET data", J Psychiatr Res, 37, pp.267~275 (2003)
  41. Schönfeldt-Lecuona C, "Accuracy of stereotaxic positioning of transcranial magnetic stimulation", Brain Topogr, 17, pp.253~259 (2005)
  42. Pommier B, "Easy methods to make the neuronavigated targeting of DLPFC accurate and routinely accessible for rTMS", Neurophysiol Clin, 47, pp.35~46 (2017)
  43. Sack AT, "Optimizing functional accuracy of TMS in cognitive studies : a comparison of methods", J Cogn Neurosci, 21, pp.207~221 (2009)
  44. Ahdab R, "Comparison of “standard” and “navigated”procedures of TMS coil positioning over motor, premotor and prefrontal targets in patients with chronic pain and depression", Neurophysiol Clin, 40, pp.27~36 (2010)
  45. Li CT, "Antidepressant mechanism of add-on repetitive transcranial magnetic stimulation in medicationresistant depression using cerebral glucose metabolism", J Affect Disord, 127, pp.219~229 (2010)
  46. Li CT, "Impaired prefronto-thalamic functional connectivity as a key feature of treatment-resistant depression: a combined MEG, PET and rTMS study", PLoS One, 8, pp.e70089~ (2013)
  47. Blumberger DM, "Unilateral and bilateral MRItargeted repetitive transcranial magnetic stimulation for treatment-resistant depression: a randomized controlled study", J Psychiatry Neurosci, 41, pp.E58~E66 (2016)
  48. Li CT, "Antidepressant efficacy of prolonged intermittent theta burst stimulation monotherapy for recurrent depression and comparison of methods for coil positioning: a randomized, double-blind, sham-controlled study", Biol Psychiatry, 87, pp.443~450 (2020)
  49. Drevets WC, "The subgenual anterior cingulate cortex in mood disorders", CNS spectr, 13, pp.663~681 (2008)
  50. Mayberg HS, "Targeted electrode-based modulation of neural circuits for depression", J Clin Invest, 119, pp.717~725 (2009)
  51. Blumberger DM, "Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression(THREED) : a randomised non-inferiority trial", Lancet, 391, pp.1683~1692 (2018)
  52. Valiulis V, "The use of MR‑less MNI based neuronavigation for 10 Hz rTMS depression therapy:electrophysiological and clinical implications", Acta Neurobiol Exp, 78, pp.271~280 (2018)
  53. Fox MD, "Identification of reproducible individualized targets for treatment of depression with TMS based on intrinsic connectivity", Neuroimage, 66, pp.151~160 (2013)
  54. Herwig U, "Spatial congruence of neuronavigated transcranial magnetic stimulation and functional neuroimaging", Clin Neurophysiol, 113, pp.462~468 (2002)
  55. Fox MD, "Measuring and manipulating brain connectivity with resting state functional connectivity magnetic resonance imaging(fcMRI)and transcranial magnetic stimulation(TMS)", Neuroimage, 62, pp.2232~2243 (2012)
  56. Lefaucheur JP, "The value of navigation-guided rTMS for the treatment of depression : an illustrative case", Neurophysiol Clin, 37, pp.265~271 (2007)
  57. Luber BM, "Reprint of ‘‘Using neuroimaging to individualize TMS treatment for depression : toward a new paradigm for imaging-guided intervention’’", Neuroimage, 151, pp.65~71 (2017)
  58. Baeken C, "HF-rTMS treatment in medication-resistant melancholic depression : results from 18FDG-PET brain imaging", CNS Spectr, 14, pp.439~448 (2009)
  59. Baeken C, "HF-rTMS treatment decreases psychomotor retardation in medication-resistant melancholic depression", Prog Neuropsychopharmacol Biol Psychiatry, 34, pp.684~687 (2010)
  60. Schrijvers DL, "The impact of high-frequency repetitive transcranial magnetic stimulation on fine motor functions in medicationresistant major depression", Neuropsychobiology, 66, pp.252~258 (2012)
  61. Baeken C, "Intensive HF-rTMS treatment in refractory medication-resistant unipolar depressed patients", J Affect Disord, 151, pp.625~631 (2013)
  62. Baeken C, "Self-directedness : an indicator for clinical response to the HF-rTMS treatment in refractory melancholic depression", Psychiatry Res, 220, pp.269~274 (2014)
  63. Wu GR, "Longer depressive episode duration negatively influences HF-rTMS treatment response : a cerebellar metabolic deficiency", Brain Imaging Behav, 11, pp.8~16 (2017)
  64. Hayasaka S, "Lateralized hippocampal volume increase following high-frequency left prefrontal repetitive transcranial magnetic stimulation in patients with major depression", Psychiatry Clin Neurosci, 71, pp.747~758 (2017)
  65. Fava M, "Definition and epidemiology of treatment-resistant depression", Psychiatr Clin North Am, 19, pp.179~200 (1996)
  66. Noda Y, "Resting-state EEG gamma power and theta-gamma coupling enhancement following high-frequency left dorsolateral prefrontal rTMS in patients with depression", Clin Neurophysiol, 128, pp.424~432 (2017)
  67. Wall CA, "Magnetic resonance imaging-guided, open-label, high-frequency repetitive transcranial magnetic stimulation for adolescents with major depressive disorder", J Child Adolesc Psychopharmacol, 26, pp.582~589 (2016)
  68. Padberg F, "Repetitive transcranial magnetic stimulation of the prefrontal cortex in depression", Exp Neurol, 219, pp.2~13 (2009)
  69. Bystritsky A, "A preliminary study of fMRI-guided rTMS in the treatment of generalized anxiety disorder", J Clin Psychiatry, 69, pp.1092~1098 (2008)
  70. Fox MD, "Clinical applications of resting state functional connectivity", Front Syst Neurosci, 4, pp.19~ (2010)
  71. Weigand A, "Prospective validation that subgenual connectivity predicts antidepressant efficacy of transcranial magnetic stimulation sites", Biol Psychiatry, 84, pp.28~37 (2018)
  72. Philip NS, "Network mechanisms of clinical response to transcranial magnetic stimulation in posttraumatic stress disorder and major depressive disorder", Biol Psychiatry, 83, pp.263~272 (2018)
  73. Siddiqi SH, "Abstract# 155 : Individualized connectivity between rTMS targets and the subgenual cingulate is unrelated to antidepressant response", Brain Stimul, 12, pp.e53~ (2019)
  74. Taylor SF, "Changes in brain connectivity during a sham-controlled, transcranial magnetic stimulation trial for depression", J Affect Disord, 232, pp.143~151 (2018)
  75. Wang L, "Effective connectivity of the fronto-parietal network during attentional control", J Cogn Neurosci, 22, pp.543~553 (2010)
  76. Siddiqi SH, "Repetitive transcranial magnetic stimulation with resting-state network targeting for treatment-resistant depression in traumatic brain injury: a randomized, controlled, double-blinded pilot study", J Neurotrauma, 36, pp.1361~1374 (2019)
  77. Greicius MD, "Resting-state functional connectivity in major depression : abnormally increased contributions from subgenual cingulate cortex and thalamus", Biol Psychiatry, 62, pp.429~437 (2007)
  78. Spreng RN, "Intrinsic architecture underlying the relations among the default, dorsal attention, and frontoparietal control networks of the human brain", J Cogn Neurosci, 25, pp.74~86 (2013)
  79. Connolly CG, "Resting-state functional connectivity of subgenual anterior cingulate cortex in depressed adolescents", Biol Psychiatry, 74, pp.898~907 (2013)
  80. Gao W, "Frontal parietal control network regulates the anti-correlated default and dorsal attention networks", Hum Brain Mapp, 33, pp.192~202 (2012)
  81. Siddiqi SH, "Individualized connectome-targeted transcranial magnetic stimulation for neuropsychiatric sequelae of repetitive traumatic brain injury in a retired NFL player", J Neuropsychiatry Clin Neurosci, 31, pp.254~263 (2019)
  82. Iwabuchi SJ, "Targeted transcranial theta-burst stimulation alters fronto-insular network and prefrontal GABA", Neuroimage, 146, pp.395~403 (2017)
  83. Iwabuchi SJ, "Baseline effective connectivity predicts response to repetitive transcranial magnetic stimulation in patients with treatment-resistant depression", Eur Neuropsychopharmacol, 29, pp.681~690 (2019)
  84. -fluorodeoxyglucose PET and MRI study, "Int J Neuropsychopharmacol", 2010, 45~59
  85. Klein E, "Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression : a double-blind controlled study", Arch Gen Psychiatry, 56, pp.315~320 (1999)
  86. Fitzgerald PB, "A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression", Am J Psychiat, 163, pp.88~94 (2006)
  87. Downar J, "New targets for rTMS in depression : a review of convergent evidence", Brain Stimul, 6, pp.231~240 (2013)
  88. Fan J, "Segregation of salience network predicts treatment response of depression to repetitive transcranial magnetic stimulation", NeuroImage-Clin, 22, pp.101719~ (2019)
  89. Zanardi R, "Role of serotonergic gene polymorphisms on response to transcranial magnetic stimulation in depression", Eur Neuropsychopharmacol, 17, pp.651~657 (2007)
  90. Cheeran B, "A common polymorphism in the brainderived neurotrophic factor gene(BDNF)modulates human cortical plasticity and the response to rTMS", J Physiol, 586, pp.5717~5725 (2008)
  91. Bocchio-Chiavetto L, "5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression", Neurosci Lett, 437, pp.130~134 (2008)
  92. 최지욱, "경두개 자기자극술의 실제", 생물치료정신의학, 11(1), pp.5~11 (2005), 대한생물치료정신의학회

이 간행물의 다른 논문 (7건)

케타민의 항우울 효과와 임상적 적용김병수pp. 79-87정신 질환에서 고압산소요법의 임상 적용에 대한 고찰김정윤, 하은지, 주윤지, 홍가혜, 김래영, 남궁은pp. 88-100경두개직류자극술의 인지기능 개선 작용기전에 대한 고찰 : 기능적 자기공명영상 연구를 중심으로강일향, 김정윤, 김신혜, 홍가혜, 홍혜진, 김진솔, 이향원pp. 116-126청소년에서 인터넷 게임중독에 미치는 인자김상훈, 박상학, 서은현, 윤형준, 김승곤, 양혜정pp. 127-133국내 일반인구에서의 정신병적 경험의 유병률 및 정신질환과의 연관성이지민, 김병수, 장서영, 김혜림, 장성만, 김현준pp. 134-143
원문 보기